Difluoromethylornithine chemoprevention of epidermal carcinogenesis in K14-HPV16 transgenic mice

被引:0
作者
Arbeit, JM
Riley, RR
Huey, B
Porter, C
Kelloff, G
Lubet, R
Ward, JM
Pinkel, D
机构
[1] Univ Calif San Francisco, Mt Zion Med Ctr, Dept Surg, San Francisco, CA 94143 USA
[2] NCI, Div Canc Chemoprevent, Bethesda, MD 20262 USA
[3] Roswell Pk Mem Canc Ctr, Grace Canc Drug Ctr, Buffalo, NY 14263 USA
[4] NCI, Off Lab & Anim Sci, Vet & Tumor Pathol Sect, Frederick, MD 21702 USA
[5] Univ Calif San Francisco, Ctr Canc, San Francisco, CA 94143 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To be informative for chemoprevention, animal models must both closely emulate human disease and possess surrogate endpoint biomarkers that facilitate rapid drug screening. This study elucidated site-specific histopathological and biochemical surrogate endpoint biomarkers of spontaneous epidermal carcinogenesis in K14-HPV16 transgenic mice and demonstrated that the incidence and severity of these markers were decreased by the ornithine decarboxylase (ODC) inhibitor difluoromethylornithine (DFMO), The cumulative incidence of visible epidermal cancers in 127 untreated transgenic mice was 42% by 52 weeks of age, most frequently affecting the chest as flat lesions in association with chronic ulcers, or in the ear as protuberant masses. Microscopic malignancies were detected in 39% of 32-week-old transgenic mice and were found to emerge from precursor lesions that were of two distinct types: dysplastic sessile ear papillomas and hyperproliferative follicular/interfollicular chest dysplasias, ODC activity and tissue polyamine contents were differentially elevated in ear and chest skin during carcinogenesis, such that there was a marked elevation of both parameters of polyamine metabolism as early as 4 weeks of age in the ear, whereas in the chest, polyamine metabolism was increased significantly only in the late stages of neoplastic progression and in epidermal cancers. Administration of 1.0% DFMO in the drinking water from 4 to 32 weeks of age prevented both visible and microscopic malignancies and significantly decreased the incidence of chest and ear precursor lesions, ODC activity and tissue putrescine content were markedly diminished by DFMO chemoprevention in ear skin, whereas there was a more modest decline of these parameters in chest skin. DFMO treatment of transgenic mice from 28 to 32 weeks of age was associated with an absence of ear cancer and a marked regression of dysplastic papillomas, In contrast, the results in chest skin were complex in that the severity of chest precursors diminished, but their incidence was unchanged, and microscopic cancers were still detectable within these lesions. Collectively, this study highlights the utility of multistage epidermal carcinogenesis in K14-HPV16 transgenic mice both for the study of the biology of, and as a screening tool for, novel drugs and chemopreventive regimens.
引用
收藏
页码:3610 / 3620
页数:11
相关论文
共 50 条
[41]   Vitamin A deficiency in K14E7HPV expressing transgenic mice facilitates the formation of malignant cervical lesions [J].
Ocadiz-Delgado, Rodolfo ;
Serafin-Higuera, Nicolas ;
Alvarez-Rios, Elizabeth ;
Garcia-Villa, Enrique ;
Tinajero-Rodriguez, Manuel ;
Rodriguez-Uribe, Genaro ;
Escobar-Wilches, Derly-Constanza ;
Estela Albino-Sanchez, Marta ;
Ramirez-Rosas, Alejandro ;
Sierra-Santoyo, Adolfo ;
Hernandez-Pando, Rogelio ;
Lambert, Paul ;
Gariglio, Patricio .
APMIS, 2021, 129 (08) :512-523
[42]   Expression of lymphomagenic oncogenes in T-Cell lymphomas of HPV 16 transgenic mice [J].
Yang, JT ;
Liu, CZ ;
Domer, P ;
Iannaccone, P .
CANCER DETECTION AND PREVENTION, 1998, 22 (05) :405-415
[43]   Chemical carcinogenesis resistant FVB/K14/IL-101α transgenic mice show enhanced immune responses to epicutaneous antigen [J].
Murphy, J ;
Tamura, N ;
Kupper, T .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1999, 112 (04) :647-647
[44]   THE HPV-16 GENOME INDUCES CARCINOMAS AND T-CELL LYMPHOMAS IN TRANSGENIC MICE [J].
YANG, JT ;
LIU, CZ ;
IANNACCONE, P .
AMERICAN JOURNAL OF PATHOLOGY, 1995, 147 (01) :68-78
[45]   Dimethylaminoparthenolide reduces the incidence of dysplasia and ameliorates a wasting syndrome in HPV16-transgenic mice [J].
Santos, Joana M. O. ;
Moreira-Pais, Alexandra ;
Neto, Tiago ;
da Silva, Sara Peixoto ;
Oliveira, Paula A. ;
Ferreira, Rita ;
Mendes, Joaquim ;
Bastos, Margarida M. S. M. ;
Lopes, Carlos ;
Casaca, Fatima ;
Silva, Sandra ;
Sweeney, Christopher ;
Medeiros, Rui ;
Gil da Costa, Rui M. .
DRUG DEVELOPMENT RESEARCH, 2019, 80 (06) :824-830
[46]   Retinoblastoma dependent and independent functions of epidermal keratin K10 in transgenic mice [J].
Santos, M ;
Ruiz, S ;
Segrelles, C ;
Vooijs, M ;
Leis, H ;
Jorcano, JL ;
Paramio, JM .
FASEB JOURNAL, 2003, 17 (05) :A978-A978
[47]   CHEMOPREVENTION OF COLON CARCINOGENESIS BY DIETARY ADMINISTRATION OF PIROXICAM, ALPHA-DIFLUOROMETHYLORNITHINE, 16-ALPHA-FLUORO-5-ANDROSTEN-17-ONE, AND ELLAGIC ACID INDIVIDUALLY AND IN COMBINATION [J].
RAO, CV ;
TOKUMO, K ;
RIGOTTY, J ;
ZANG, E ;
KELLOFF, G ;
REDDY, BS .
CANCER RESEARCH, 1991, 51 (17) :4528-4534
[48]   Promotion of skin carcinogenesis by dimethylarsinic acid in keratin (K6)/ODC transgenic mice [J].
Morikawa, T ;
Wanibuchi, H ;
Morimura, K ;
Ogawa, M ;
Fukushima, S .
JAPANESE JOURNAL OF CANCER RESEARCH, 2000, 91 (06) :579-581
[49]   HPV16 is sufficient to induce squamous cell carcinoma specifically in the tongue base in transgenic mice [J].
Mestre, Veronica F. ;
Medeiros-Fonseca, Beatriz ;
Estevao, Diogo ;
Casaca, Fatima ;
Silva, Sandra ;
Felix, Ana ;
Silva, Fernanda ;
Colaco, Bruno ;
Seixas, Fernanda ;
Bastos, Margarida M. S. M. ;
Lopes, Carlos ;
Medeiros, Rui ;
Oliveira, Paula A. ;
da Costa, Rui M. .
JOURNAL OF PATHOLOGY, 2020, 251 (01) :4-11
[50]   Regulation of cell growth and cell death in the mouse retina in HPV-16 transgenic mice. [J].
Lee, D ;
Griep, AE ;
Albert, D ;
Lambert, PF .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1997, 38 (04) :154-154